Controlled release from particles encapsulated by molecular layer deposition

US10245233B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10245233-B2
Application numberUS-201615552122-A
CountryUS
Kind codeB2
Filing dateFeb 25, 2016
Priority dateFeb 25, 2015
Publication dateApr 2, 2019
Grant dateApr 2, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides a slow-release material comprising particles, wherein the particles comprise a core comprising an active component and a multilayer shell, wherein the multi-layer shell comprises a molecular layer deposition (MLD) multi-layer, wherein the active component comprises one or more of a pharmaceutical compound and a nutraceutical compound, for use in the treatment of a disease.

First claim

Opening claim text (preview).

The invention claimed is: 1. A slow-release material ( 1 ) comprising particles ( 100 ), wherein the particles ( 100 ) comprise a core ( 110 ) comprising an active component ( 10 ) and a multi-layer shell ( 120 ), wherein the multi-layer shell ( 120 ) comprises a molecular layer deposition (MLD) multi-layer ( 1200 ), wherein the active component comprises one or more of a pharmaceutical compound and a nutraceutical compound, for use in the treatment of a disease, and wherein each layer ( 121 ) of the multi-layer shell ( 120 ) comprises a group defined by formula (I): wherein R1, R2, R3, and R4 are independently selected from the group consisting of a carbon comprising group, wherein Z1 and Z2 are each independently selected from an oxygen or nitrogen comprising group, and wherein R2 is optionally present. 2. The slow-release material ( 1 ) according to claim 1 , wherein the core ( 110 ) comprises a diameter (d 1 ) selected from the range of 1 nm - 2 mm, and wherein the multi-layer shell ( 120 ) comprises in the range of 2-1000 layers ( 121 ). 3. The slow-release material ( 1 ) according to claim 1 , wherein a first molecular layer ( 121 a ) is covalently linked to a surface ( 111 ) of the core ( 110 ). 4. The slow-release material ( 1 ) according to claim 3 , wherein R1=R3=C, R2=CH 2 , R4=-(CH 2 )C(CH 2 CH 3 )—, and Z1=Z2=O. 5. The slow-release material ( 1 ) according to claim 1 , wherein the active component ( 10 ) comprises a pharmaceutical compound, and wherein the core further comprises a pharmaceutically acceptable carrier and/or a pharmaceutically acceptable filler. 6. The slow-release material ( 1 ) according to claim 1 , wherein the active component ( 10 ) comprised by said core ( 110 ) has an active component solubility in water, wherein the multi-layer shell ( 120 ) has a multi-layer shell solubility in water, wherein the multi-layer shell solubility is smaller than the active component solubility. 7. A core-shell particle ( 100 ), comprising a core ( 110 ) comprising an active component ( 10 ) and a shell ( 120 ), wherein the shell ( 120 ) comprises a plurality of polymers, with each polymer attached with one end to the core, and each polymer comprises a plurality of groups defined by formula (I): wherein R1, R2, R3, and R4 are independently selected from the group consisting of a carbon comprising group, wherein Z1 and Z2 are each independently selected from an oxygen or nitrogen comprising group, and wherein R2 is optionally present. 8. A method for the production of a slow-release material ( 1 ) according to claim 1 , the method comprising: fluidizing particles ( 100 ) comprising an active component ( 10 ) in a reactor ( 1000 ), wherein the active component comprises one or more of a pharmaceutical compound and a nutraceutical compound; applying molecular multi-layer deposition with self-terminating reactions on said fluidized particles ( 100 ) in said reactor ( 1000 ), wherein sequentially compounds (II) and (III) are reacted: wherein R1, R2, R3, and R4 are independently selected from the group consisting of a carbon comprising group, wherein R2 is optionally present, wherein A1 and A2 are independently selected from OH, Cl, and —OR5, wherein R5 is selected from the group consisting of a carbon comprising group and a silicon comprising group, wherein Z11 and Z12 are each independently selected from an OH comprising group, an NH comprising group and an NH 2 comprising group; removing the thus obtained particles from said reactor ( 1000 ), to provide said slow-release material ( 1 ). 9. The method according to claim 8 , wherein during the molecular multi-layer deposition the reactor ( 1000 ) is subjected to a vibration having a frequency selected from the range of 1-200 Hz. 10. The method according to claim 8 , wherein the reactor has a top part ( 1076 ), wherein the method further includes providing a counter flow ( 1020 ) from the top part ( 1076 ) into the reactor ( 1000 ). 11. The method according to claim 10 , wherein the counter flow ( 1020 ) is provided into the reactor ( 1000 ) via a micro jet ( 1004 ). 12. The method according to claim 8 , wherein the molecular multi-layer deposition is executed at a temperature selected from the range of 35-150° C. and at a pressure selected from the range of 0.8-2 bar. 13. The method according to claim 8 , wherein the particles ( 100 ) comprise a surface ( 111 ) comprising amine groups. 14. The method according to claim 8 , wherein a number of times sequentially three compounds are reacted, and wherein the thus obtained molecular layer deposition (MLD) multi-layer ( 1200 ) comprises a stack of layers ( 121 ) with each layer ( 121 ) comprising the reaction product of the three compounds. 15. The method according to claim 8 , wherein one or more of the self-terminating reactions comprise a ring opening reaction. 16. The method according to claim 8 , wherein compound (II) is selected from an oligo carboxylic acid and an oligo acid chloride analogue, and wherein compound (III) is selected from a polyol and a polyamine. 17. The method according to claim 8 , wherein the core ( 110 ) comprises a diameter (d 1 ) selected from the range of 1 nm-2 mm, and wherein the method comprises applying molecular multi-layer deposition until a multi-layer shell ( 120 ) of 2-100 layers ( 121 ) is obtained. 18. The method according to claim 8 , further comprising one or more of providing an additional coating, producing a dosage form comprising the slow-release material ( 1 ), and packaging the slow-release material ( 1 ) or dosage form, respectively. 19. The method according to claim 8 , wherein the method comprises depositing a molecular layer deposition (MLD) multi-layer ( 1200 ) onto particles being pneumatically transported in a tube, said process comprising: (i) providing a tube having an inlet opening and an outlet opening; (ii) feeding a carrier gas entraining particles into the tube at or near the inlet opening of the tube to create a particle flow through the tube; (iii) injecting a first reactant into the tube via an injection point downstream from the inlet opening of the tube for deposition on the surface of the particles in the particle flow in a self-terminating reaction; and (iv) injecting a second reactant into the tube via a further injection point downstream from the injection point of the first reactant for deposition on the surface of the particles in the particle flow in a self-terminating reaction. 20. A reactor ( 1000 ) for producing the slow-release material according to claim 1 , wherein said reactor fluidizes said particles ( 110 ) comprising a diameter (d 1 ) selected from the range of 1 nm - 2 mm, wherein the reactor ( 1000 ) comprises a first inlet ( 1001 ) for introduction of one or more reactants in the gas phase, wherein the reactor ( 1000 ) further comprises a vibration generator ( 1600 ) configured to subject the reactor ( 1000 ) to a vibration having a frequency selected from the range of 1-200 Hz, wherein the reactor ( 1000 ) further comprises a second inlet ( 1002 ) for a gas, configured to provide during operation a counter flow relative to a flow introduced in the reactor ( 1000 ) via the first inlet ( 1001 ).

Assignees

Inventors

Classifications

  • using fluidised-bed technique (fluidised-bed technique in general B01J8/24) · CPC title

  • according to "fluidised-bed" technique (B01J8/20 takes precedence) · CPC title

  • Processes · CPC title

  • Flow distribution elements · CPC title

  • with fluidised bed subjected to vibrations or pulsations · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10245233B2 cover?
The invention provides a slow-release material comprising particles, wherein the particles comprise a core comprising an active component and a multilayer shell, wherein the multi-layer shell comprises a molecular layer deposition (MLD) multi-layer, wherein the active component comprises one or more of a pharmaceutical compound and a nutraceutical compound, for use in the treatment of a disease.
Who is the assignee on this patent?
Univ Delft Tech
What technology area does this patent fall under?
Primary CPC classification A61K9/5073. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).